Biotechnology

Palo Alto, 4 August (AKI) - Doctor Roberto Crea, one of the pioneers of biotechnology announced on Monday that he has filed a lawsuit against the City of Hope Medical Center located in the western U.S. city of Duarte, California.According to court documents, Genentech has paid over 700 million dollars to City of Hope Medical Center in exchange for the assignment of these patents, synthetic DNA and technical knowhow under the City of Hope - Genentech agreement.Crea's lawsuit is based on the claim that his two former colleagues, Keiichi ...

NEW YORK, July 21 /PRNewswire/ -- Ari Kiev, M.D., president of SPRI Clinical Trials, will be a featured speaker at the upcoming conference Wall Street Unplugged: The Trout Group Investor Seminar -- Management's Guide to Wall Street. The conference will be held on Wednesday, July 30, at Midtown Loft & Terrace, 267 Fifth Avenue in New York. The event is targeted to CEOs and CFOs at private and small and mid-cap life science companies to gain better insight into Wall Street and maximize communication with the investment community.Dr. Kie ...

WORCESTER, Mass., July 16, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM:GNBT - News), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, received a purchase order for the approximate amount of $300,000 through its Generex MENA office from a distributor in Saudi Arabia.``We are very encouraged by the significant purchase orders generated by the Generex MENA office in such a short time frame,'' said Bill Abajian, the company's Senior Executive Advisor for Global Business Dev ...

HOUSTON--(BUSINESS WIRE)--Power3 Medical Products, Inc. (OTCBB:PWRM), a leading proteomics company specializing in the development and commercialization of early detection diagnostic tests for breast cancer and neurodegenerative diseases, today announced a new major international collaboration. Power3, in partnership with the Princess Haya Biotechnology Center and the Jordan University of Science and Technology will begin a clinical validation study for Power3's BC-SeraPro' Breast Cancer diagnostic blood test. The collaborative projec ...

New Rochelle, NY, July 8, 2008-Biotech and pharmaceutical firms are developing a host of new technologies designed to streamline the complicated drug discovery process, reports Genetic Engineering and Biotechnology News (GEN). Most successful approaches rely on a combination of high-throughput screening methods, miniaturization techniques, and advanced data-analysis tools, according to an article in the July issue (http://www.genengnews.com/articles/chitem.aspx?aid=2527) of GEN."The key goal for companies trying to develop new drugs i ...

Generex Biotechnology Corporation (NasdaqCM:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, has commenced dosing of patients in a Phase III clinical trial of the Company's flagship product, Generex Oral-lynO, an oral insulin spray.The six-month Phase III study will involve up to 750 patients with Type-1 Diabetes Mellitus in thirty-six centers located in the United States, Canada, Russia, and Eastern Europe. The objective of the study is to compare the efficacy of Generex Oral-lyn and th ...

ROME (Reuters) - Biotechnology can help solve the world's food crisis with benefits such as flood-resistant rice in Bangladesh or higher cotton yields in Burkina Faso, a senior U.S. official said at a U.N. food summit on Tuesday."Biotechnology is one of the most promising tools for improving the productivity of agriculture and increasing the incomes of the rural poor," U.S. Agriculture Secretary Ed Schafer said."We are convinced of the benefits it offers to developing countries and small farmers," he told a U.S.-led briefing on the si ...

Innovation Corridor to Include Daily Presentations for the First Time EverWASHINGTON - Academics and industry leaders will showcase their innovative ideas on the next groundbreaking technologies in the life sciences at the 2008 BIO International Convention's Innovation Corridor poster sessions. Hosted by the Biotechnology Industry Organization (BIO), the global event for biotechnology will take place June 17-20 at the San Diego Convention Center in San Diego, Calif.The Innovation Corridor will play host to presentations representing m ...

This expertly written report effectively evaluates the biotechnology and pharma drug market on the grounds of innovation, growth and FDA approvals and provides a critical analysis of both industries principal products, as well as the active and evolving biotech/pharma relationship.The biotechnology drug market is doing well, but big pharma s sudden interest in big molecules is turning out to be the predominant factor determining the future of the biotech therapeutics industry. This report analyzes that dynamic, in addition to other is ...

New Delhi, May 12: The Centre today announced a 'special grant' of Rs 100 crore to the Kerala-based Rajiv Gandhi Centre for Biotechnology (RGCB) to further develop the Infrastructure and other facilities at the 12-year-old premier advanced research institute.Science and Technology Minister Kapil Sibal said the special grant would be over and above the normal grants-in-aid to the Institute at Thiruvananthapuram, which was recently taken over by the Union Government under the Department of Biotechnology.Talking to mediapersons on the si ...

PRINCETON, New Jersey, May 12 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS - News), a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections, is pleased to announce that it has been selected to join the NASDAQ Biotechnology Index effective with the market open on May 19, 2008.The NASDAQ Biotechnology Index is the basis for the iShares NASDAQ Biotechnology Index(sm) Fund (AMEX: IBB - News), which seeks investment results that correspond generally to the pri ...

ARLINGTON, Va., May 6 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR - News), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, announced today the completion of a Service Agreement with Concordia Pharmaceuticals, Inc. and initiation of preclinical studies to evaluate new applications for Salirasib using Champions Biotechnology's Biomerk Tumorgrafts(TM)."Our Biomerk Tumorgraft preclinical platform and its benefits in ...

Prana Biotechnology Limited has announced that it has identified novel therapeutic drug candidates from its Parkinson's disease program. Already, a lead candidate drug has demonstrated positive effects in pre-clinical studies, protecting the brain from damage to the substantia nigra, the area of the brain affected in Parkinson's disease.Prana's drug candidates are being tested on two widely used mouse models for Parkinson's disease, which employ either the 6-hydroxy-dopamine (6-OHDA) or MPTP toxins. These models mimic the disease by u ...

Food prices are escalating globally, sparking protests and demonstrations worldwide. Datuk Dr Abd Shukor Abd Rahman, director-general of the Malaysian Agricultural Research and Development Institute (Mardi) tells TAN CHOE CHOE that biotechnology, and genetically modified food crops, may be the answer to Malaysia's food problems Q: Is Malaysia on the verge of a food crisis?A: If you look at the news reports, it seems we are. But we have measures -- short- and long-term -- to address food shortages and it will be announced by the minist ...

GBI is one of the earliest biopharmaceutical contract manufacturing organizations (CMOs), established in 1992. GBI specializes in process development and cGMP compliant mammalian cell culture manufacturing of bio-therapeutics for pre-clinical studies through Phase III clinical trials. The company and its predecessor, The Goodwin Institute for Cancer Research, have been operating in the biologics CMO sector since the early 1980's. GBI's clients include small to midsized biotech companies throughout North America and Europe, universitie ...

CHICAGO - Biotechnology is the key to meeting rising worldwide demand for food and alternative fuels, by boosting agricultural production, producing biofuels from energy crops, and increasing the efficiency of biofuel production, according to many of the speakers at BIO's World Congress on Industrial Biotechnology and Bioprocessing. The annual conference of more than 1200 scientists, business leaders, and government officials ended today in Chicago.Richard Hamilton, president and CEO of Ceres, Inc. noted that biotechnology can help in ...

Sustainability was on the minds of many of today's speakers at the World Congress on Industrial Biotechnology and Bioprocessing, an annual conference attracting more than 1200 scientists, business leaders, and government officials that began in full today in Chicago.John Heissenbuttel of Heissenbuttel Natural Resource Consulting announced a new industry initiative to ensure that advanced biofuels are produced in a sustainable manner. Called the Council for Sustainable Biomass Production, the group is bringing together farmers, biofuel ...

Biotech stocks open mixed following ImClone loss, Gilead study data, as broader market falls NEW YORK (AP) -- Shares of biotechnology companies opened mixed Thursday after ImClone Systems Inc. reported a big loss for the first quarter, while Gilead Sciences Inc. released positive data from a drug study.The American Stock Exchange's biotechnology index fell 18.7 points, or 2.5 percent, to 738.37. The index tracks several bellwether stocks. The Nasdaq Stock Market's biotechnology index, which covers a broader range of small- and midcap ...

UT's 'talented and productive' scientists help with growthThe biotechnology sector in Austin has undergone significant growth since UT biology adjunct professor Matthew Winkler started the company Ambion 20 years ago.When Ambion began operations in 1989, there were only a couple of biotechnology companies in Austin. It was a "virtual vacuum," Winkler said. While Austin's biotechnology hub does not compare to hubs in San Diego or Boston, it has gained traction in the field.Winkler sold Ambion in 2006 and created another biotechnology c ...

16th International Trade Fair with Conference Program, Partnering Event and Biotechnology Award (7 - 9 October) -- Cooperation with the European Association of Pharma Biotechnology (EAPB) and European BioPerspectives HANNOVER, Germany - BIOTECHNICA 2008 will be staging the first separate meeting-place for pharmaceutical biotechnology. This year's event will see the debut of the new platform "Science to Market" staged by the European Association of Pharma Biotechnology (EAPB), which represents joint cooperation with European BioPerspec ...

WASHINGTON, D.C. (Tuesday, April 15, 2008) - The Biotechnology Industry Organization (BIO) invites leaders from biotechnology, chemical and agricultural industries to submit proposals for panels and individual papers for the third annual Pacific Rim Summit on Industrial Biotechnology and Bioenergy. The conference will be held Sept. 10 - 12, 2008, at the Westin Bayshore Resort & Marina in Vancouver, B.C., Canada.Leaders from the biotechnology industry, academia, and science community are invited to submit proposals for panels in any of ...

NEW YORK - New York Biotechnology Association (NYBA), the voice of New York State's biotechnology industry, announced today that it will feature two new pre-conference workshops as part of its 17th Annual Meeting: Women in Biotechnology and the Regulatory and Policy Affairs Workshop. These events will take place simultaneously between 1:00 and 5:30 PM, Sunday, May 18th, at the Marriott Marquis Hotel in New York City. Admission is free to pre-registered 17th Annual Meeting attendees, $75 for NYBA members, $100 to non-members and $30 fo ...

Genetically modified crops have been widely adopted by American farmers. In spite of their use in the United States, the European Union (EU) imposed a 6-year freeze (1998-2004) on growing and importing transgenic crops.In 2002, transgenic food aid to African nations was rejected by the recipient governments. The EU's stand on agricultural biotechnology no doubt contributed to this decision.Lori Unruh Snyder, Department of Agronomy, Purdue University, along with others, shares how to teach using this discussion-based scenario in the 20 ...

European Union (EU) and India are set to strengthen their biotechnology research ties, particularly in the fields of food and health, following recent visits by EU officials to India and Indian officials to Brussels.A delegation from the EU recently visited India to discuss cooperation over issues such as the links between health and nutrition and how these can be exploited to help prevent chronic diseases, according to the CORDIS press service of the European Commission."We went there with a group of leading EU scientists and we want ...

The Spanish Association of Bioenterprises (ASEBIO) has presented a poster with the portfolio of healthcare products that are being researched by Spanish biotech companies. This Spanish sector pipeline includes 28 companies contributing a total of 119 projects on drugs and diagnosis systems for use on humans and 12 products for animal health care.Jorge Barrero, ASEBIO General Secretary has highlighted that "this presentation initiative from the Spanish biotechnology sector forms part of a more ambitious programme of activities that wil ...

Genetically modified crops have been widely adopted by American farmers. In spite of their use in the United States, the European Union (EU) imposed a 6-year freeze (1998-2004) on growing and importing transgenic crops.In 2002, transgenic food aid to African nations was rejected by the recipient governments. The EU's stand on agricultural biotechnology no doubt contributed to this decision.Lori Unruh Snyder, Department of Agronomy, Purdue University, along with others, shares how to teach using this discussion-based scenario in the 20 ...

Costa Rica could lose a multi-million euro donation from the European Union (EU) to build and equip a new biotechnology centre.The laboratory - the National Centre for Biotechnology Innovations (CENIBiot) - was formally unveiled more than two years ago, but work has yet to start due to delays in the process of awarding contracts to builders and suppliers.This has led the EU to warn that if the delays are still continuing by December this year the ?11 million (about US$17 million) donation could be withdrawn.Roelf Smit, first councillo ...

Patient Screening Underway in North America for the Company's Non-Injectable Insulin That is Absorbed in the Lining of the Mouth and Does Not Enter the Lungs Generex Biotechnology Corporation (NasdaqCM:GNBT - News), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has initiated the Phase III protocol in North America for its proprietary buccally-absorbed oral insulin spray product, Generex Oral-lyn(tm), with the commencement of patient screening. The first screening took ...

Out of research facilities around Florida there is a steady flow of new ideas and tools that will become the means of fighting disease, improving health and enhancing lives.This week's meeting of the Biotechnology Legislative Caucus in Tallahassee was eye-opening for that reason. Rather than a litany of technical reports or legislative analysis, the meeting consisted of snapshots from Jacksonville, Miami and Sarasota about the latest science and the business prospects for spin-offs of various innovations.Dr. Thomas G. Brott, director ...

Biotechnology is spreading across the whole country, according to a recent survey.Statistics New Zealand released figures from the Biotechnology Survey 2007 today which showed 21 percent of biotechnology organisations were from the Auckland and the rest were "spread evenly across the remainder of the country".The survey showed 67 percent of biotechnologies used in New Zealand were at the research and development stage .In the two years to June 2007, 225 biotechnology patents were granted. ...

Rewrite the textbooks on cancer.Transform cancer from a killer disease into a manageable chronic disease such as high blood pressure.Develop cures for cancer.Those are unimaginable notions today, but the possibilities are real as biotechnology, still in its infancy, continues to unfold and change the face of cancer and other disease treatment, said Dr. Susan Desmond-Hellmann, president of product development for San Francisco-based Genentech, a leader in the biotechnology industry in the U.S."What we are trying to do is change medicin ...

A new study is raising doubts about one of the hottest fields in biotechnology.That field, called RNA interference, is supposed to provide a way to precisely turn off specific disease-causing genes. Biotech start-ups and big pharmaceutical companies are racing to develop drugs to harness this mechanism.But the study suggests that at least some of the drugs now being tested in clinical trials actually work not by silencing genes but by activating the immune system. That could mean the drugs are not totally precise tools and could have ...

Ardana, a former white hope of the Scottish biotechnology sector, moved yesterday to stem the collapse in its share price by announcing it had received a number of takeover approaches.The company's shares, quoted at 108p a year ago, had crashed to 41p by the start of the year, and to 28p before Ardana announced on February 19 that it was looking for a sale or merger. It had lost another two-thirds of its market value by Wednesday, collapsing to 9.5p or little more than its likely cash pile. The price almost doubled to 18.25p on yester ...

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD - News), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at The 8th Annual Fortis Bank Biotechnology Conference on Thursday, April 3, 2008, at 10:00 a.m. Western European Time at the Four Seasons Hotel London in London, England.About ACADIA PharmaceuticalsACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug disc ...

Research and Markets has announced the addition of "Marine Biotechnology - Global Strategic Business Report" to their offering.This report analyzes the worldwide markets for Marine Biotechnology in Millions of US$. The major product segments analyzed are Marine Biomaterials, Marine Bioactive Substances, and Others. The Major End-Use Applications Analyzed are Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services & Infrastructure, and Others. The report provides separate comprehensive analytics for the Unite ...

On March 31, 2008, ANSI will convene follow-up meeting for U.S. stakeholders interested in international standardization issues in biotechnology arena. Meeting will build upon issues discussed during Jan 10 biotechnology strategy session and Jan 21-22 meeting of ISO CSC/STRAT. As ISO takes these issues under consideration, ANSI's meeting will further the dialogue with U.S. biotechnology experts and offer follow-up information on status and next steps of proposed standardization activities. ...

Reportlinker.com announces that a new market research report related to the Agricultural chemicals industry is available in its catalogue.This report analyzes the worldwide markets for Marine Biotechnology in Millions of US$. The major product segments analyzed are Marine Biomaterials, Marine Bioactive Substances, and Others. The Major End-Use Applications Analyzed are Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services & Infrastructure, and Others. The report provides separate comprehensive analytics fo ...

ZIOPHARM Oncology, Inc. announced today Dr. Jonathan Lewis, Chief Executive Officer, will present at the 8th Annual Fortis Bank Biotechnology Conference on Thursday, April 3, 2008 at 2:00 p.m. GMT (9:00 a.m. ET) at the Four Seasons Hotel Park Lane in London, United Kingdom.Dr. Lewis will provide an overview of the Company and an update on the clinical development programs. The presentation will be available on the Company's website at www.ziopharm.com.About ZIOPHARM Oncology, Inc.ZIOPHARM Oncology, Inc. is a biopharmaceutical company ...

A grant for west central Wisconsin will fund training for nearly 135 workers in biotechnology and renewable energy.Roberta Gassman is the secretary of the state Department of Workforce Development.She presented the $85,000 dollar check to Workforce Resource, Inc. Monday during a visit to Western Wisconsin Energy in Boyceville.The money will fund training for up to 135 workers there."This grant is very important one as we help grow this industry in our state and make sure we've got workers who can do this work. It's a great partnership ...

Some experts have questioned the feasibility of Congress's new biofuels mandate, but emerging biotechnologies may boost the industry above and beyond expectations.Traditional corn ethanol has received a bad rap in the popular press lately due to concerns increased production and conversion of corn into fuel may increase emissions and raise food prices.Not everyone agrees with these assertions, but almost everyone does agree the fuel of the future will not rely on corn kernels, but on new feedstock options called cellulosic sources. Th ...